Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akshat Sarkari

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Biochemical Society Transactions|July 22, 2024
Do tunneling nanotubes drive chemoresistance in solid tumors and other malignancies?Akshat Sarkari, Emil Lou
Results and Problems in Cell Differentiation|September 6, 2024
Tunneling Nanotubes: Implications for ChemoresistanceSanyukta Padmanabhan, Karina Deniz, Akshat Sarkari, et al.
Cancers|June 12, 2026
The Evolving Landscape of Systemic Therapy for LiposarcomaHee Kyung Kim, Akshat Sarkari, Warren A Chow
Lung Cancer (Auckland, N.Z.)|May 20, 2026
HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib - A Case ReportMisako Nagasaka, Zhaohui L Arter, Cathleen J Park, et al.
Frontiers in Cell and Developmental Biology|October 19, 2018
Cellular and Molecular Networking Within the Ecosystem of Cancer Cell Communication via Tunneling NanotubesEmil Lou, Edward Zhai, Akshat Sarkari, et al.
Elife|November 13, 2023
Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesotheliomaAkshat Sarkari, Sophie Korenfeld, Karina Deniz, et al.
Scientific Reports|June 23, 2018
Chemotherapy-Induced Tunneling Nanotubes Mediate Intercellular Drug Efflux in Pancreatic CancerSnider Desir, Patrick O'Hare, Rachel Isaksson Vogel, et al.
STAR Protocols|January 10, 2025
Protocol for applying Tumor Treating Fields in mouse models of cancer using the inovivo systemTravis J Gates, Sewar Zbidat, Karina Deniz, et al.
Iscience|October 7, 2025
SARS-CoV-2 infection drives local inflammation of the intestinal epithelium in immunocompromised patients with cancerEmil Lou, Christine Luo, Katherine Ladner, et al.
Annals of Surgery|October 28, 2025
SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment of Localized Pancreatic Cancer : A Multicenter, Retrospective Cohort StudyJulia Button, Elishama Kanu, Ethan Agritelley, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biochemical Society Transactions|July 22, 2024
Do tunneling nanotubes drive chemoresistance in solid tumors and other malignancies?Akshat Sarkari, Emil Lou
Results and Problems in Cell Differentiation|September 6, 2024
Tunneling Nanotubes: Implications for ChemoresistanceSanyukta Padmanabhan, Karina Deniz, Akshat Sarkari, et al.
Cancers|June 12, 2026
The Evolving Landscape of Systemic Therapy for LiposarcomaHee Kyung Kim, Akshat Sarkari, Warren A Chow
Lung Cancer (Auckland, N.Z.)|May 20, 2026
HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib - A Case ReportMisako Nagasaka, Zhaohui L Arter, Cathleen J Park, et al.
Frontiers in Cell and Developmental Biology|October 19, 2018
Cellular and Molecular Networking Within the Ecosystem of Cancer Cell Communication via Tunneling NanotubesEmil Lou, Edward Zhai, Akshat Sarkari, et al.
Elife|November 13, 2023
Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesotheliomaAkshat Sarkari, Sophie Korenfeld, Karina Deniz, et al.
Scientific Reports|June 23, 2018
Chemotherapy-Induced Tunneling Nanotubes Mediate Intercellular Drug Efflux in Pancreatic CancerSnider Desir, Patrick O'Hare, Rachel Isaksson Vogel, et al.
STAR Protocols|January 10, 2025
Protocol for applying Tumor Treating Fields in mouse models of cancer using the inovivo systemTravis J Gates, Sewar Zbidat, Karina Deniz, et al.
Iscience|October 7, 2025
SARS-CoV-2 infection drives local inflammation of the intestinal epithelium in immunocompromised patients with cancerEmil Lou, Christine Luo, Katherine Ladner, et al.
Annals of Surgery|October 28, 2025
SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment of Localized Pancreatic Cancer : A Multicenter, Retrospective Cohort StudyJulia Button, Elishama Kanu, Ethan Agritelley, et al.
Pageof 2